Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine

Prog Pediatr Cardiol. 2014 Dec 1;37(1-2):23-27. doi: 10.1016/j.ppedcard.2014.10.006.
No abstract available